Lyric Bio
Next Generation Biomanufacturing
San Francisco, United States · $6.6M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- lyricbio.com
- Total Funding
- $6.6M
- Last Round
- $6.6M SeedDec 2025
- Rounds
- 1
About
Lyric Bio is building next-generation biomanufacturing platforms for human donor-sourced therapeutics.
Summary
Lyric Bio is a Biotech company based in San Francisco, United States. It has raised $6.6M in total across 1 round, most recently a $6.6M Seed round in Dec 2025. Investors include The Venture Collective, Black Diamond Ventures and Draper Associates.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.